Skip to main content

Business

By Jessica Hagen | 01:39 pm | January 09, 2024
The funding marks the completion of the company's merger with Amelia Virtual Care, and the investment will be used to support the combined companies' growth.
By HIMSS TV | 07:00 am | January 09, 2024
Rachini Moosavi, University of North Carolina Health chief analytics officer, relays how UNC began developing AI in 2016, deploying the tech within clinical and financial operations, and how providers have responded to AI implementation.  
By HIMSS TV | 07:00 am | January 08, 2024
Albert Marinez, chief analytics officer at Cleveland Clinic, relates how the health system uses AI to ease provider workflow, the responses it has received from physicians and lessons learned throughout the implementation process.  
By Jessica Hagen | 02:22 pm | January 05, 2024
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.
By Jessica Hagen | 04:00 pm | January 04, 2024
The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.
By HIMSS TV | 07:00 am | January 04, 2024
Sara Shanti, partner at Sheppard Mullin, discusses the intersection of healthcare and technology, how to establish trust and transparency within AI, and questions she receives pertaining to virtual therapy, particularly in mental health.
By Jessica Hagen | 04:09 pm | January 03, 2024
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
By HIMSS TV | 07:00 am | January 03, 2024
Providers are responsible for navigating variable coverage schemes while caring for patients, says Jay Rughani, investment partner at Andreessen Horowitz. AI and LLMs advancements can help fix this trajectory and reduce administrative burnout.  
By Jessica Hagen | 05:52 pm | January 02, 2024
The funds come two years after the company scored a $1.15 billion investment.
By Jessica Hagen | 02:13 pm | January 02, 2024
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.